Zhoujun Shen

3.9k total citations
108 papers, 2.4k citations indexed

About

Zhoujun Shen is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Urology. According to data from OpenAlex, Zhoujun Shen has authored 108 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Surgery, 34 papers in Endocrinology, Diabetes and Metabolism and 29 papers in Urology. Recurrent topics in Zhoujun Shen's work include Bladder and Urothelial Cancer Treatments (22 papers), Adrenal and Paraganglionic Tumors (21 papers) and Urinary Bladder and Prostate Research (18 papers). Zhoujun Shen is often cited by papers focused on Bladder and Urothelial Cancer Treatments (22 papers), Adrenal and Paraganglionic Tumors (21 papers) and Urinary Bladder and Prostate Research (18 papers). Zhoujun Shen collaborates with scholars based in China, United States and Austria. Zhoujun Shen's co-authors include Tianyuan Xu, Shan Zhong, Zhaowei Zhu, Yingli Lu, Yuan Shao, Xianjin Wang, Xianjin Wang, Guo‐Liang Lu, Wenbin Rui and Yu Zhu and has published in prestigious journals such as PLoS ONE, Scientific Reports and FEBS Letters.

In The Last Decade

Zhoujun Shen

106 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhoujun Shen China 29 1.1k 878 670 479 392 108 2.4k
Joaquı́n Carballido Spain 25 845 0.8× 310 0.4× 424 0.6× 106 0.2× 729 1.9× 204 2.4k
Ettore Mearini Italy 32 714 0.7× 147 0.2× 683 1.0× 409 0.9× 923 2.4× 137 2.6k
Yoshifumi Kadono Japan 24 328 0.3× 186 0.2× 343 0.5× 272 0.6× 234 0.6× 158 1.8k
M Kontturi Finland 26 563 0.5× 558 0.6× 379 0.6× 152 0.3× 844 2.2× 107 2.4k
Vincenzo Altieri Italy 25 680 0.6× 107 0.1× 794 1.2× 364 0.8× 225 0.6× 104 2.1k
Alois Gessl Austria 28 493 0.5× 1.1k 1.2× 527 0.8× 98 0.2× 161 0.4× 87 2.6k
Yan-qun Na China 21 294 0.3× 143 0.2× 562 0.8× 166 0.3× 465 1.2× 134 1.7k
Anne M. Pippen United States 23 367 0.3× 167 0.2× 870 1.3× 173 0.4× 51 0.1× 32 2.4k
Po‐Hui Chiang Taiwan 26 591 0.5× 168 0.2× 158 0.2× 81 0.2× 1.1k 2.8× 126 2.2k
Kostandinos Sideras United States 22 259 0.2× 1.1k 1.3× 668 1.0× 249 0.5× 37 0.1× 57 2.6k

Countries citing papers authored by Zhoujun Shen

Since Specialization
Citations

This map shows the geographic impact of Zhoujun Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhoujun Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhoujun Shen more than expected).

Fields of papers citing papers by Zhoujun Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhoujun Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhoujun Shen. The network helps show where Zhoujun Shen may publish in the future.

Co-authorship network of co-authors of Zhoujun Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhoujun Shen. A scholar is included among the top collaborators of Zhoujun Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhoujun Shen. Zhoujun Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Na, Rong, Yishuo Wu, Guangliang Jiang, et al.. (2018). Germline mutations in DNA repair genes are associated with bladder cancer risk and unfavourable prognosis. British Journal of Urology. 122(5). 808–813. 11 indexed citations
2.
Dong, Fan, Yifan Shen, Tianyuan Xu, et al.. (2018). Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: a systematic review and meta-analysis. World Journal of Surgical Oncology. 16(1). 61–61. 12 indexed citations
3.
Zhang, Ying, Wenquan Niu, Fangfang Zheng, et al.. (2017). Identifying unilateral disease in Chinese patients with primary aldosteronism by using a modified prediction score. Journal of Hypertension. 35(12). 2486–2492. 13 indexed citations
4.
Wang, Xiaojing, et al.. (2017). Targeting of CCN2 suppresses tumor progression and improves chemo-sensitivity in urothelial bladder cancer. Oncotarget. 8(39). 66316–66327. 7 indexed citations
5.
Liao, Limin, Ben Wan, Wei Li, et al.. (2016). Results of a randomized, double‐blind, active‐controlled clinical trial with propiverine extended release 30 mg in patients with overactive bladder. British Journal of Urology. 119(1). 148–157. 3 indexed citations
6.
Zheng, Fangfang, Aifang Nie, Jingrong Lin, et al.. (2015). Clinical Characteristics of Somatic Mutations in Chinese Patients With Aldosterone-Producing Adenoma. Hypertension. 65(3). 622–628. 117 indexed citations
7.
Xu, Tianyuan, Xianjin Wang, Leilei Xia, et al.. (2014). Robot-Assisted Prostatectomy in Obese Patients: How Influential Is Obesity on Operative Outcomes?. Journal of Endourology. 29(2). 198–208. 25 indexed citations
8.
Zhao, Juping, Xiaolong Jing, Wenlong Zhou, et al.. (2014). The diagnosis and treatment of primary adrenal lipomatous tumors in Chinese patients: a 31-year follow-up study. Canadian Urological Association Journal. 8(3-4). 132–132. 19 indexed citations
9.
Zhu, Zhaowei, Xianjin Wang, Zhoujun Shen, et al.. (2013). Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies. BMC Cancer. 13(1). 310–310. 66 indexed citations
10.
Xu, Tianyuan, Zhaowei Zhu, Xianjin Wang, et al.. (2013). Predicting Recurrence and Progression in Chinese Patients With Nonmuscle-invasive Bladder Cancer Using EORTC and CUETO Scoring Models. Urology. 82(2). 387–393. 26 indexed citations
11.
12.
Wan, Ben, Wei Li, Keji Xie, et al.. (2012). Randomized clinical trial evaluating safety and efficacy of propiverine ER 30 mg and tolterodine ER 4 mg in the treatment of overactive bladder. 1 indexed citations
13.
Shen, Zhoujun, et al.. (2012). Engagement of Integrinβ1 Induces Resistance of Bladder Cancer Cells to Mitomycin-C. Urology. 79(3). 638–643. 11 indexed citations
14.
Li, Tao, Li R, Yuhua Li, et al.. (2012). miR-21 as an Independent Biochemical Recurrence Predictor and Potential Therapeutic Target for Prostate Cancer. The Journal of Urology. 187(4). 1466–1472. 109 indexed citations
15.
Zhu, Yu, Hongchao He, Tingwei Su, et al.. (2010). Selective α1-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma. Endocrine. 38(2). 254–259. 35 indexed citations
16.
Shen, Zhoujun, X. Wang, Yu Zhu, et al.. (2009). UP-1.016: Retroperitoneoscopic Partial Adrenalectomy for Aldosteronoma: Clinical Experiences with 163 Cases. Urology. 74(4). S175–S175. 1 indexed citations
17.
Shen, Zhoujun, Yuan Shao, Rui Wu, X. Wang, & Yue Teng. (2009). UP-3.186: Retroperitoneal Laparoscopic Pyelolithotomy for Complicated Renal Calculi. Urology. 74(4). S352–S352. 1 indexed citations
18.
19.
Shen, Zhoujun, Shan-Wen Chen, Yingli Lu, et al.. (2005). Preliminary study on androgen dependence of calcitonin gene-related peptide in rat penis. Asian Journal of Andrology. 7(1). 55–59. 3 indexed citations
20.
Shen, Zhoujun, et al.. (2004). [Erectile function evaluation after adult circumcision].. PubMed. 10(1). 18–9. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joaquı́n Carballido Breakdown of academic impact, for papers by Ettore Mearini Breakdown of academic impact, for papers by Yoshifumi Kadono Breakdown of academic impact, for papers by M Kontturi Breakdown of academic impact, for papers by Vincenzo Altieri Breakdown of academic impact, for papers by Alois Gessl Breakdown of academic impact, for papers by Yan-qun Na Breakdown of academic impact, for papers by Anne M. Pippen Breakdown of academic impact, for papers by Po‐Hui Chiang Breakdown of academic impact, for papers by Kostandinos Sideras
Rankless by CCL
2026